Tuesday, May 12, 2020

India's Jubilant Signs Licensing Deal For US Pharma Firm's COVID-19 Drug

India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries,...

from NDTV News - Special https://ift.tt/3bqUqQ1
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Viral Video Shows 3,000 Engineers Queuing Up For Job Interview In Pune

In a viral video, over 3,000 engineers were seen queuing outside a Pune-based company for a recent walk-in drive targeting junior developer ...